ADC Therapeutics SA (ADCT) Ownership

$1.45

north_east
$0.02 (1.05%)
Day's range
$1.44
Day's range
$1.49

ADC Therapeutics SA Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
REDMILE GROUP, LLC 02/14/2025 15.67 M $31.18 M   -0.02% 14.95%
PROSIGHT MANAGEMENT, LP 02/14/2025 9.52 M $18.93 M   -1.26% 9.08%
ORBIMED ADVISORS LLC 02/14/2025 5.97 M $11.88 M   31.64% 5.69%
BLACKROCK, INC. 02/07/2025 5.01 M $9.97 M   13.93% 4.78%
MORGAN STANLEY 02/14/2025 3.96 M $7.87 M   30.10% 3.77%
WOODLINE PARTNERS LP 02/14/2025 1.93 M $3.85 M   100.00% 1.84%
GOLDMAN SACHS GROUP INC 02/11/2025 1.67 M $3.33 M   -0.91% 1.60%
PLATINUM INVESTMENT MANAGEMENT LTD 02/11/2025 1.61 M $3.21 M   11.63% 1.54%
BANK OF AMERICA CORP /DE/ 02/14/2025 1.29 M $2.57 M   -48.31% 1.23%
STATE STREET CORP 02/14/2025 1.19 M $2.36 M   7.43% 1.13%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 963.11 K $1.92 M   1.04% 0.92%
UBS GROUP AG 02/14/2025 884.52 K $1.76 M   2,123.80% 0.84%
VANTAGE CONSULTING GROUP INC 02/12/2025 850.74 K $1.69 M   0.00% 0.81%
BLUE OWL CAPITAL HOLDINGS LP 02/14/2025 733.57 K $1.46 M   0.00% 0.70%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 716.67 K $1.43 M   100.00% 0.68%
VANGUARD GROUP INC 02/11/2025 644.62 K $1.28 M   19.52% 0.61%
NORTHERN TRUST CORP 02/14/2025 476.19 K $947.62 K   -1.01% 0.45%
MILLENNIUM MANAGEMENT LLC 02/14/2025 411.12 K $818.14 K   -42.29% 0.39%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 253.34 K $504.15 K   50.30% 0.24%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 224.08 K $445.92 K   9.80% 0.21%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 194.26 K $386.57 K   0.00% 0.19%
TWO SIGMA INVESTMENTS, LP 02/14/2025 183.23 K $364.63 K   -25.29% 0.17%
BANK OF NEW YORK MELLON CORP 02/04/2025 171.99 K $342.27 K   6.01% 0.16%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 152.05 K $302.57 K   17.81% 0.15%
BARCLAYS PLC 02/13/2025 141.50 K $282.00 K   10.77% 0.14%
FMR LLC 02/13/2025 127.02 K $252.77 K   139.47% 0.12%
SANIBEL CAPTIVA TRUST COMPANY, INC. 01/15/2025 113.00 K $224.87 K   0.00% 0.11%
RHUMBLINE ADVISERS 01/30/2025 110.04 K $218.96 K   15.60% 0.11%
SQUAREPOINT OPS LLC 02/14/2025 107.23 K $213.39 K   42.23% 0.10%
BRYN MAWR TRUST CO 01/28/2025 100.00 K $199.00 K   0.00% 0.10%
TWO SIGMA ADVISERS, LP 02/14/2025 65.27 K $129.88 K   122.94% 0.06%
CITIGROUP INC 02/12/2025 64.14 K $127.64 K   8.89% 0.06%
DEUTSCHE BANK AG\ 02/14/2025 56.06 K $111.56 K   40.70% 0.05%
MAGNETAR FINANCIAL LLC 02/11/2025 55.76 K $110.97 K   0.00% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 51.20 K $101.88 K   100.00% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 46.52 K $92.58 K   21.54% 0.04%
WELLS FARGO & COMPANY/MN 02/13/2025 41.83 K $83.25 K   39.45% 0.04%
COREBRIDGE FINANCIAL, INC. 02/11/2025 40.43 K $80.46 K   -7.02% 0.04%
COMMONWEALTH EQUITY SERVICES, LLC 02/10/2025 39.61 K $79.00 K   -1.98% 0.04%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 39.36 K $78.33 K   78.05% 0.04%
INTECH INVESTMENT MANAGEMENT LLC 02/11/2025 38.44 K $76.49 K   195.70% 0.04%
JPMORGAN CHASE & CO 02/12/2025 37.02 K $73.67 K   -53.03% 0.04%
SG AMERICAS SECURITIES, LLC 01/17/2025 36.14 K $72.00 K   35.57% 0.03%
INVESCO LTD. 02/13/2025 34.37 K $68.40 K   5.20% 0.03%
METLIFE INVESTMENT MANAGEMENT, LLC 02/13/2025 31.12 K $61.92 K   -27.78% 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 28.90 K $57.51 K   100.00% 0.03%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 28.83 K $58.00 K   0.00% 0.03%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 28.59 K $56.89 K   10.67% 0.03%
DLK INVESTMENT MANAGEMENT, LLC 01/16/2025 25.81 K $51.35 K   -22.17% 0.02%
LPL FINANCIAL LLC 02/11/2025 25.00 K $49.75 K   100.00% 0.02%

ADC Therapeutics SA institutional Ownership - FAQ's

During the previous two years, 85 institutional investors and hedge funds held shares of ADC Therapeutics SA. The most heavily invested institutionals were:

Redmile Group, LLC: 15.67 M

Prosight Management, LP: 9.52 M

ORBIMED ADVISORS LLC: 5.97 M

MORGAN STANLEY: 3.96 M

Woodline Partners LP: 1.93 M

GOLDMAN SACHS GROUP INC: 1.67 M

53.89% of ADC Therapeutics SA stock is owned by institutional investors.

Institutional investors have bought a total of 57.44 M shares in the last 24 months. This purchase volume represents approximately $82.99 M in transactions.